bpc-157 tb-500 human studies tendon healing Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC-157: Tendon Repair and More
Description
A new Phase 2 trial (NCT07437547, sponsor Hudson Biotech) is testing BPC-157 against placebo in 120 participants with MRI-confirmed acute Grade II hamstring strain, randomized and double-blind
Patients should report side effects, concerns, or health changes
Blended formulations allow researchers to evaluate interaction effects, signal amplification, and pathway modulation under controlled conditions
Side effects management at each dose level Every dose level carries different side effect profiles
